Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AVUS
#6938
Avantis U.S. Equity ETF
118.3
4
USD
+0.03%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.03%
Monthly Change
+5.18%
6 month change
+8.99%
Year Change
+36.07%
Previous Close
118.3
0
Open
118.4
2
Bid
Ask
Low
118.3
4
High
118.4
2
Volume
3
Markets
US Stock Market
Financial
AVUS
Open full chart
Top holdings
Market Value
Shares
Weight %
AAPL
Apple Inc
553.3 M
2.0 M
5.4%
NVDA
NVIDIA Corp
504.0 M
2.8 M
4.9%
MSFT
Microsoft Corp
427.7 M
869.3 K
4.2%
AMZN
Amazon.com Inc
357.0 M
1.5 M
3.5%
GOOGL
Alphabet Inc
293.5 M
916.5 K
2.9%
META
Meta Platforms Inc
258.7 M
399.2 K
2.5%
JPM
JPMorgan Chase & Co
149.9 M
478.7 K
1.5%
AVGO
Broadcom Inc
138.5 M
343.6 K
1.3%
XOM
Exxon Mobil Corp
96.5 M
832.5 K
0.9%
TSLA
Tesla Inc
89.8 M
208.8 K
0.9%
LLY
Eli Lilly & Co
87.3 M
81.2 K
0.9%
V
Visa Inc
77.9 M
233.0 K
0.8%
CAT
Caterpillar Inc
74.2 M
128.9 K
0.7%
Berkshire Hathaway Inc
73.0 M
142.1 K
0.7%
COST
Costco Wholesale Corp
71.2 M
77.9 K
0.7%
WMT
Walmart Inc
69.9 M
632.6 K
0.7%
JNJ
Johnson & Johnson
69.4 M
335.4 K
0.7%
LRCX
Lam Research Corp
62.8 M
402.4 K
0.6%
MA
Mastercard Inc
62.7 M
114.0 K
0.6%
NFLX
Netflix Inc
61.8 M
574.3 K
0.6%
News
Large Caps - Big Opportunity
3 Best ETFs to Invest In, According to AI Analyst, 04/07/2026 - TipRanks.com
Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019
AVUS: A Middle-Ground Sector Exposure With Attractive Valuation (NYSEARCA:AVUS)
Small Cap Momentum Moderates
Sentiment Sours On AI Substitution
Small-Cap Stocks Are Stirring On Policy Shifts, Earnings Edge
AVUS: Impressive Depth Of Exposure But Imperfect Risk-Adjusted Returns (NYSEARCA:AVUS)
Equity Market Outlook Q1 2026: Macro Tailwinds Galore, But Mind The Risks
Benchmark Blind Spots: Detecting Hidden Risks In Disruptive Markets
Medical Products Leader In Base After 36% Stock Surge On Blowout Quarterly Earnings
Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope